These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 14963047)

  • 1. Impaired Shc, Ras, and MAPK activation but normal Akt activation in FL5.12 cells expressing an insulin-like growth factor I receptor mutated at tyrosines 1250 and 1251.
    Leahy M; Lyons A; Krause D; O'Connor R
    J Biol Chem; 2004 Apr; 279(18):18306-13. PubMed ID: 14963047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
    Besset V; Scott RP; Ibáñez CF
    J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RACK1-mediated integration of adhesion and insulin-like growth factor I (IGF-I) signaling and cell migration are defective in cells expressing an IGF-I receptor mutated at tyrosines 1250 and 1251.
    Kiely PA; Leahy M; O'Gorman D; O'Connor R
    J Biol Chem; 2005 Mar; 280(9):7624-33. PubMed ID: 15611085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
    Mur C; Valverde AM; Kahn CR; Benito M
    Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
    Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M
    Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol.
    Krause D; Lyons A; Fennelly C; O'Connor R
    J Biol Chem; 2001 Jun; 276(22):19244-52. PubMed ID: 11278392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
    Gu J; Tamura M; Yamada KM
    J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor.
    Hayashi H; Ichihara M; Iwashita T; Murakami H; Shimono Y; Kawai K; Kurokawa K; Murakumo Y; Imai T; Funahashi H; Nakao A; Takahashi M
    Oncogene; 2000 Sep; 19(39):4469-75. PubMed ID: 11002419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
    Kurihara S; Hakuno F; Takahashi S
    Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
    Tyagi A; Agarwal R; Agarwal C
    Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells.
    Lu Y; Zi X; Zhao Y; Pollak M
    Biochem Biophys Res Commun; 2004 Jan; 313(3):709-15. PubMed ID: 14697248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells.
    Ling Y; Maile LA; Lieskovska J; Badley-Clarke J; Clemmons DR
    Mol Biol Cell; 2005 Jul; 16(7):3353-64. PubMed ID: 15888547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts.
    Conejo R; Lorenzo M
    J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth defects induced by perturbation of beta1-integrin function in the mammary gland epithelium result from a lack of MAPK activation via the Shc and Akt pathways.
    Faraldo MM; Deugnier MA; Thiery JP; Glukhova MA
    EMBO Rep; 2001 May; 2(5):431-7. PubMed ID: 11375936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes.
    Sharma PM; Son HS; Ugi S; Ricketts W; Olefsky JM
    Mol Endocrinol; 2005 Feb; 19(2):421-30. PubMed ID: 15486046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that basal activity, but not transactivation, of the epidermal growth factor receptor tyrosine kinase is required for insulin-like growth factor I-induced activation of extracellular signal-regulated kinase in oral carcinoma cells.
    Kuribayashi A; Kataoka K; Kurabayashi T; Miura M
    Endocrinology; 2004 Nov; 145(11):4976-84. PubMed ID: 15271882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained activation of MAPK/ERKs signaling pathway in cystic kidneys from bcl-2 -/- mice.
    Sorenson CM; Sheibani N
    Am J Physiol Renal Physiol; 2002 Nov; 283(5):F1085-90. PubMed ID: 12372784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domains of the insulin-like growth factor I receptor required for the activation of extracellular signal-regulated kinases.
    Dews M; Prisco M; Peruzzi F; Romano G; Morrione A; Baserga R
    Endocrinology; 2000 Apr; 141(4):1289-300. PubMed ID: 10746631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA; Surmacz E
    Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival.
    Zheng WH; Quirion R
    J Neurochem; 2004 May; 89(4):844-52. PubMed ID: 15140184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.